NO864139L - Polypeptid virksomt ved dannelse av aids-antistoff. - Google Patents

Polypeptid virksomt ved dannelse av aids-antistoff.

Info

Publication number: NO864139L
Authority: NO; Norway
Prior art keywords: creation; polypeptide effective; aids antibody; aids; antibody
Prior art date: 1985-10-17

Application number

NO864139A

Other languages

English (en)

Other versions

NO864139D0 (no

Inventor

Wilhelm Bannwarth

Ulrich Certa

Jan Mous

Dietrich Stueber

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-10-17

Filing date

1986-10-16

Publication date

1987-04-21

1986-10-16 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1986-10-16 Publication of NO864139D0 publication Critical patent/NO864139D0/no

1987-04-21 Publication of NO864139L publication Critical patent/NO864139L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Virology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO864139A 1985-10-17 1986-10-16 Polypeptid virksomt ved dannelse av aids-antistoff. NO864139L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB858525615A GB8525615D0 (en)	1985-10-17	1985-10-17	Polypeptides

Publications (2)

Publication Number	Publication Date
NO864139D0 NO864139D0 (no)	1986-10-16
NO864139L true NO864139L (no)	1987-04-21

Family

ID=10586812

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO864139A NO864139L (no)	1985-10-17	1986-10-16	Polypeptid virksomt ved dannelse av aids-antistoff.

Country Status (11)

Country	Link
EP (1)	EP0219106A3 (no)
JP (1)	JPS6299398A (no)
AU (1)	AU602315B2 (no)
BR (1)	BR8605053A (no)
DK (1)	DK496486A (no)
ES (7)	ES2009210A6 (no)
GB (1)	GB8525615D0 (no)
IL (1)	IL80304A0 (no)
NO (1)	NO864139L (no)
NZ (1)	NZ217895A (no)
ZA (1)	ZA867748B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL76082A (en) *	1984-08-22	1991-07-18	Us Health	Molecular clones of the genome of htlv-iii and a process for the preparation thereof
US4879212A (en) *	1986-04-02	1989-11-07	United Biomedical Inc.	Peptide composition and method for the detection of antibodies to HTLV-III
US4925784A (en) *	1986-04-04	1990-05-15	Hoffmann-La Roche Inc.	Expression and purification of an HTLV-III gag/env gene protein
EP0247557B1 (en) *	1986-05-27	1994-04-20	F. Hoffmann-La Roche Ag	HTLV-III(LAV) Envelope peptides
WO1987007616A1 (en) *	1986-06-12	1987-12-17	Biogen N.V.	Peptides involved in the pathogenesis of hiv infection
US5087557A (en) *	1986-06-23	1992-02-11	Genetic Systems Corporation	Human monoclonal antibody to lymphadenopathy-associated virus
NZ221440A (en) *	1986-08-20	1991-11-26	Genetic Systems Corp	Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections
US5166050A (en) *	1986-08-20	1992-11-24	Bristol-Myers Squibb Company	Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections
NO881151L (no) *	1987-03-27	1988-09-28	Syntello Ab	Syntetisk hiv-1-antigen.
GB8714802D0 (en) *	1987-06-24	1987-07-29	Proteus Biotech Ltd	Synthetic polypeptides
IL87391A0 (en) *	1987-08-27	1989-01-31	Repligen Corp	Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
SE8704185L (sv) *	1987-10-28	1989-04-29	Ferring Ab	Nya peptider, artificiella antigener och immunoanalystestsatser
EP0323157A3 (en) *	1987-12-24	1990-07-25	The University Of Melbourne	Antiviral compounds and methods
US6214537B1 (en)	1988-01-27	2001-04-10	Biochem Immunosystems, Inc.	Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) *	1988-12-08	1993-08-31	Biochem Pharma Inc.	Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6218102B1 (en) *	1988-01-27	2001-04-17	Biochem Immunosystems, Inc.	Synthetic peptides and mixtures thereof for detecting HIV antibodies
AU629528B2 (en) *	1988-01-27	1992-10-08	Biochem Pharma Inc.	Synthetic peptides and mixtures thereof for detecting hiv antibodies
US6210874B1 (en)	1988-01-27	2001-04-03	Biochem Immunosystems, Inc.	Synthetic peptides and mixtures thereof for detecting HIV antibodies
SE8802176D0 (sv) *	1988-06-10	1988-06-10	Kabigen Ab	Fusion protein and its use
IL91462A0 (en) *	1988-08-30	1990-04-29	Applied Research Systems	Recombinant fusion proteins and dna encoding for such a protein
ATE118247T1 (de) *	1988-09-27	1995-02-15	Dana Farber Cancer Inst Inc	Vektor, der ein replikationskompetentes hiv-i- provirus und ein heterologes gen enthält.
US6228608B1 (en) *	1991-02-28	2001-05-08	Aquila Biopharmaceuticals, Inc.	Recombinant FIV glycoprotein 160 and P24 gag protein
US6316004B1 (en) *	1993-06-22	2001-11-13	T. Tikhonenko	Chimeric somatostatin containing protein and encoding DNA, plasmids of expression, method for preparing chimeric protein, strain-producers, immunogenic composition, method for increasing the productivity of farm animals
IT1271486B (it) *	1993-10-12	1997-05-28	Italfarmaco Spa	Oligopeptidi immunomodulatori derivati di frammenti della proteina c- reattiva
DE4405810A1 (de)	1994-02-23	1995-08-24	Behringwerke Ag	Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung
FR2732346B1 (fr) *	1995-03-27	1997-05-30	Centre Nat Rech Scient	Proteines mutees, codees par un gene env mute de lentivirus, fragments peptidiques inclus dans lesdites proteines, vecteurs d'expression exprimant lesdites proteines mutees et leurs applications
CA2288869A1 (en) *	1998-03-04	1999-09-10	Mary Ann Childs	Rapid confirmatory test for microbial infections
ATE508139T1 (de)	2003-04-11	2011-05-15	Pasteur Institut	Synthetische peptid-hiv-vakzine: das cbd-epitop als effizientes immunogen zur induktion hiv- neutralisierender antikörper
EP3461813A1 (en)	2004-05-23	2019-04-03	Gerard M. Housey	Theramutein modulators
US8431110B2 (en)	2005-05-23	2013-04-30	Hmi Medical Innovations, Llc.	Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8324800D0 (en) *	1983-09-15	1983-10-19	Pasteur Institut	Antigens
EP0387915B1 (en) *	1984-10-18	1993-03-10	Institut Pasteur	F antigens of the human immunodeficiency virus, and their applications
DE3588134T2 (de) *	1984-12-24	1997-03-20	Genentech Inc	Fusionen von AIDS-verwandten Polypeptiden
US4774175A (en) *	1985-03-01	1988-09-27	Centocor, Inc.	Immunochemical methods for the detection of antibody against HTLV-III
EP0220273B2 (en) *	1985-04-29	2007-01-17	Bio-Rad Laboratories, Inc.	Synthetic antigens for the detection of aids-related disease

1985
- 1985-10-17 GB GB858525615A patent/GB8525615D0/en active Pending
1986
- 1986-10-13 ZA ZA867748A patent/ZA867748B/xx unknown
- 1986-10-13 NZ NZ217895A patent/NZ217895A/en unknown
- 1986-10-15 IL IL80304A patent/IL80304A0/xx unknown
- 1986-10-15 EP EP86114243A patent/EP0219106A3/en not_active Withdrawn
- 1986-10-16 DK DK496486A patent/DK496486A/da not_active Application Discontinuation
- 1986-10-16 AU AU63997/86A patent/AU602315B2/en not_active Ceased
- 1986-10-16 BR BR8605053A patent/BR8605053A/pt unknown
- 1986-10-16 ES ES8602630A patent/ES2009210A6/es not_active Expired
- 1986-10-16 JP JP61246454A patent/JPS6299398A/ja active Pending
- 1986-10-16 NO NO864139A patent/NO864139L/no unknown
1988
- 1988-04-29 ES ES8801337A patent/ES2009905A6/es not_active Expired
- 1988-04-29 ES ES8801340A patent/ES2006925A6/es not_active Expired
- 1988-04-29 ES ES8801339A patent/ES2009907A6/es not_active Expired
- 1988-04-29 ES ES8801342A patent/ES2010538A6/es not_active Expired
- 1988-04-29 ES ES8801341A patent/ES2014527A6/es not_active Expired - Lifetime
- 1988-04-29 ES ES8801338A patent/ES2009906A6/es not_active Expired

Also Published As

Publication number	Publication date
IL80304A0 (en)	1987-01-30
ES2010538A6 (es)	1989-11-16
ES2009907A6 (es)	1989-10-16
EP0219106A3 (en)	1989-02-08
EP0219106A2 (en)	1987-04-22
JPS6299398A (ja)	1987-05-08
NO864139D0 (no)	1986-10-16
ES2009906A6 (es)	1989-10-16
GB8525615D0 (en)	1985-11-20
DK496486A (da)	1987-04-18
ES2014527A6 (es)	1990-07-16
DK496486D0 (da)	1986-10-16
BR8605053A (pt)	1987-07-14
AU6399786A (en)	1987-04-30
ZA867748B (en)	1987-07-29
ES2009905A6 (es)	1989-10-16
ES2006925A6 (es)	1989-05-16
NZ217895A (en)	1991-05-28
AU602315B2 (en)	1990-10-11
ES2009210A6 (es)	1989-09-16

Publication	Publication Date	Title
NO864139L (no)	1987-04-21	Polypeptid virksomt ved dannelse av aids-antistoff.
FI852516A0 (fi)	1985-06-26	Anordning foer dosering av tillvaext befraemjande aemnen.
DE3786767D1 (de)	1993-09-02	Neues polypeptid.
FI862231A0 (fi)	1986-05-27	Anordning foer utkastning av spelbollar.
NO165961C (no)	1991-05-15	Fremgangsmaate til fremstilling av interferonproteiner.
FI862761L (fi)	1986-12-29	Klonad antigen.
DE3689738D1 (de)	1994-04-28	Warmverdichtung von Balgbehältern.
IT8421622A0 (it)	1984-06-27	Procedimento per la preparazione di peptidi.
DK551287A (da)	1988-04-24	Polypeptid
DK383985D0 (da)	1985-08-23	Polypeptid
NO855067L (no)	1986-06-18	Fremgangsmaate for fremstilling av n-formyl-alfa-aspartyl-fenylalanin.
DK354389D0 (da)	1989-07-18	Polypeptid
FI812822A7 (fi)	1982-03-20	Polypeptidivalmisteet.
NO861772L (no)	1986-11-07	Fremgangsmaate for fremstilling av proteinhydrolysat.
NO166931C (no)	1991-09-18	Fremgangsmaate ved fremstilling av klordioksyd.
NO853400L (no)	1986-03-03	Polypeptidvaksiner.
FI862023A0 (fi)	1986-05-14	Kontrollanordning i malmaskin.
NO165637C (no)	1991-03-13	Fremgangsmaate for fremstilling av etoksylert lignitt.
NO864386L (no)	1986-11-03	Fremgangsmaate ved fremstilling av uretaner.
NO861239L (no)	1986-10-02	Fremgangsmaate ved fremstilling av klordioksyd.
FI852772A0 (fi)	1985-07-15	Formsten.
NO863769D0 (no)	1986-09-22	Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO166709C (no)	1991-08-28	Fremgangsmaate for fremstilling av akrylamider.
FI854781L (fi)	1986-06-05	Foerfarande foer framstaellning av en multi-kopia-jaestvektor.
NO864087D0 (no)	1986-10-14	Fremgangsmaate for fremstilling av aroylthiazoloner.